Limen Advisory is a business development advisory for life science companies expanding between Europe and North America. It works with biotechs, techbio and service companies that need senior capacity without a full-time hire. Services include market-entry strategy, fractional CEO/CCO/head of BD, go-to-market design for platform and SaaS offerings, and scientific storytelling for investor and partnering meetings. Clients get an advisor who can discuss mechanism of action with R&D and contract terms with procurement.
Areas of activity
Research
Academic spin-offs & start-upsBioinformatics & computational biologyClinical research (CRO)Preclinical & translational researchTechnology transfer & open innovation
Senior BD support for life science companies entering Europe from North America, or the US from Europe: market mapping, target accounts, positioning, and first meetings with decision-makers.
Open to commercial EIR or venture partner roles with VCs, company builders, accelerators and university venture programs: deal-flow assessment, new-company building, founder coaching, portfolio BD.
Part-time senior BD leadership for life science companies with a strong offering but no commercial lead: strategy, pipeline, pharma negotiations and closing, without a full-time executive hire.
Pitch decks, non-confidential presentations and partnering-meeting preparation for scientist-founders: clear science, a credible business case, and a story investors and pharma remember.
Design and set-up of business development teams for growing life science companies: structure, hiring profiles, CRM and pipeline processes, targets and reporting.
Ongoing advice for scientist-founders at pre-seed and seed stage: business model, first pharma conversations, partner strategy, fundraising preparation, and when and whom to hire for BD.
Commercial support for tech transfer offices and research institutes: market assessment of inventions, industry-ready non-confidential summaries, licensee identification, and outreach to pharma and biotech.